Newsletter | June 29, 2020

06.29.20 -- Do Biobanks Need New Strategies?

Magazine Content
A Future-Back Approach To Transformative Therapies

To truly capture the potential of transformative innovations, many of which will take years to pay off, biopharma leaders need to trade their default “present-forward” mindset for one that is “future-back.”

Building A Legacy With Complex Assets

For life sciences executives, deciding how to manage your overall portfolio, including illiquid or complex assets, is an important step in preserving both your financial and philanthropic legacies.

Do Biobanks Need New Strategies?

Precision medicine necessitates precision research, which necessitates getting highly specific biospecimens to researchers on demand, in alignment with their demand. Researchers shouldn’t have to adjust their research to whatever specimens are available; supply needs to fit the research.

Leading With A Focus On Organizational Culture

Organizational culture is very hard to define, and even harder to get right. Many leaders believe that culture is, above all else, the most important factor in driving innovation and organizational performance.

June 2020 Digital Edition

Inside you will find more on:

  • Exclusive BioNTech CEO Interview
  • Sandoz Biosimilar Expert Q&A
  • Women In Life Sciences
  • CEO Corner Column - Leadership

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.